AAAAAA
Results: 26-50/54
Authors:
Forgione, M
Loscalzo, J
Citation: M. Forgione et J. Loscalzo, The antioxidant hypothesis, DEV CARD M, 233, 2000, pp. 47-56
Authors:
Eberhardt, RT
Loscalzo, J
Citation: Rt. Eberhardt et J. Loscalzo, Homocysteine and endothelial dysfunction, DEV CARD M, 230, 2000, pp. 371
Authors:
Loscalzo, J
Citation: J. Loscalzo, The biological chemistry of nitric oxide, CONTEMP CAR, 2000, pp. 3-10
Authors:
Battinelli, EM
Loscalzo, J
Citation: Em. Battinelli et J. Loscalzo, Nitric oxide and platelet-mediated hemostasis, CONTEMP CAR, 2000, pp. 123-138
Authors:
Rudd, MA
Trolliet, MR
Loscalzo, J
Citation: Ma. Rudd et al., Nitric oxide and hypertension, CONTEMP CAR, 2000, pp. 227-246
Authors:
Eberhardt, RT
Loscalzo, J
Citation: Rt. Eberhardt et J. Loscalzo, Nitric oxide in atherosclerosis, CONTEMP CAR, 2000, pp. 273-295
Authors:
Freedman, JE
Loscalzo, J
Citation: Je. Freedman et J. Loscalzo, Thrombotic disorders and nitric oxide insufficiency, CONTEMP CAR, 2000, pp. 297-307
Authors:
Leopold, JA
Loscalzo, J
Citation: Ja. Leopold et J. Loscalzo, S-nitrosothiols, CONTEMP CAR, 2000, pp. 411-429
Authors:
Folts, JD
Loscalzo, J
Citation: Jd. Folts et J. Loscalzo, Coating arterial and blood-contacting surfaces with NO center dot-donatingcompounds, CONTEMP CAR, 2000, pp. 503-514
Authors:
Battinelli, EM
Trolliet, MR
Loscalzo, J
Citation: Em. Battinelli et al., Nitric oxide and its role in hemostasis, EN CEL RE S, 5, 1999, pp. 229-249
Authors:
Kenet, G
Freedman, J
Shenkman, B
Regina, E
Brok-Simoni, F
Holzman, F
Vavva, F
Brand, N
Michelson, A
Trolliet, M
Loscalzo, J
Inbal, A
Citation: G. Kenet et al., Plasma glutathione peroxidase deficiency and platelet insensitivity to nitric oxide in children with familial stroke, ART THROM V, 19(8), 1999, pp. 2017-2023
Authors:
Biegelsen, ES
Loscalzo, J
Citation: Es. Biegelsen et J. Loscalzo, Endothelial function and atherosclerosis, CORON ART D, 10(4), 1999, pp. 241-256
Authors:
Maalej, N
Albrecht, R
Loscalzo, J
Folts, JD
Citation: N. Maalej et al., The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces, J AM COL C, 33(5), 1999, pp. 1408-1414
Authors:
Folts, JD
Schafer, AI
Loscalzo, J
Willerson, JT
Muller, JE
Citation: Jd. Folts et al., A perspective on the potential problems with aspirin as an antithrombotic agent: A comparison of studies in an animal model with clinical trials, J AM COL C, 33(2), 1999, pp. 295-303
Authors:
Rudd, MA
Trolliet, M
Hope, S
Scribner, AW
Daumerie, G
Toolan, G
Cloutier, T
Loscalzo, J
Citation: Ma. Rudd et al., Salt-induced hypertension in Dahl salt-resistant and salt-sensitive rats with NOSII inhibition, AM J P-HEAR, 46(2), 1999, pp. H732-H739
Authors:
Hammerman, SI
Klings, ES
Hendra, KP
Upchurch, GR
Rishikof, DC
Loscalzo, J
Farber, HW
Citation: Si. Hammerman et al., Endothelial cell nitric oxide production in acute chest syndrome, AM J P-HEAR, 277(4), 1999, pp. H1579-H1592
Authors:
Bayer, RL
Lichtman, SM
Allen, SL
Budman, DR
Buchbinder, A
Fetten, J
Kolitz, J
Loscalzo, J
Citation: Rl. Bayer et al., Acquired factor VIII inhibitors - Successful treatment with an oral outpatient regimen, AM J HEMAT, 60(1), 1999, pp. 70-71
Authors:
Levine, DZ
Friedman, EA
Lieberthal, W
Noble, J
Liebschutz, J
McCarthy, MA
Levin, R
Levinsky, NG
Kertesz, S
Loscalzo, J
Citation: Dz. Levine et al., What is our duty to a "hateful" patient? Differing approaches to a disruptive dialysis patient - Discussion, AM J KIDNEY, 34(4), 1999, pp. 786-789
Authors:
Lieberthal, W
Fuhro, R
Freedman, JE
Toolan, G
Loscalzo, J
Valeri, CR
Citation: W. Lieberthal et al., O-raffinose cross-linking markedly reduces systemic and renal vasoconstrictor effects of unmodified human hemoglobin, J PHARM EXP, 288(3), 1999, pp. 1278-1287
Authors:
Farber, HW
Loscalzo, J
Citation: Hw. Farber et J. Loscalzo, Prothrombotic mechanisms in primary pulmonary hypertension, J LA CL MED, 134(6), 1999, pp. 561-566
Authors:
Zai, A
Rudd, MA
Scribner, AW
Loscalzo, J
Citation: A. Zai et al., Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide, J CLIN INV, 103(3), 1999, pp. 393-399
Authors:
Pigazzi, A
Heydrick, S
Folli, F
Benoit, S
Michelson, A
Loscalzo, J
Citation: A. Pigazzi et al., Nitric oxide inhibits thrombin-receptor-activating peptide-induced phosphoinositide 3-kinase activity in human platelets, J BIOL CHEM, 274(20), 1999, pp. 14368-14375
Authors:
Freedman, JE
Sauter, R
Battinelli, EM
Ault, K
Knowles, C
Huang, PL
Loscalzo, J
Citation: Je. Freedman et al., Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene, CIRCUL RES, 84(12), 1999, pp. 1416-1421
Authors:
Keaney, JF
Loscalzo, J
Citation: Jf. Keaney et J. Loscalzo, Diabetes, oxidative stress, and platelet activation, CIRCULATION, 99(2), 1999, pp. 189-191
Authors:
Inbal, A
Gurevitz, O
Tamarin, I
Eskaraev, R
Chetrit, A
Novicov, I
Feldman, M
Varon, D
Eldar, M
Loscalzo, J
Citation: A. Inbal et al., Unique antiplatelet effects of a novel S-nitrosoderivative of a recombinant fragment of von Willebrand factor, AR545C: In vitro and ex vivo inhibition of platelet function, BLOOD, 94(5), 1999, pp. 1693-1700